Cargando…
Editing the Central Nervous System Through CRISPR/Cas9 Systems
The translational gap to treatments based on gene therapy has been reduced in recent years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and its variations. This has allowed the development of more precise therapies for neurodegenerative diseases, where access is priv...
Autores principales: | Cota-Coronado, Agustin, Díaz-Martínez, Néstor Fabián, Padilla-Camberos, Eduardo, Díaz-Martínez, N. Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546027/ https://www.ncbi.nlm.nih.gov/pubmed/31191241 http://dx.doi.org/10.3389/fnmol.2019.00110 |
Ejemplares similares
-
Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
por: Meneghini, Vasco, et al.
Publicado: (2021) -
Recent advances in the use of CRISPR/Cas for understanding the early development of molecular gaps in glial cells
por: Barragán-Álvarez, Carla Patricia, et al.
Publicado: (2022) -
Applications of CRISPR/Cas9 in the Mammalian Central Nervous System
por: Savell, Katherine E., et al.
Publicado: (2017) -
iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020) -
Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)